ArticleThe Journal of clinical investigation2020

AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes.

Ali Dehnad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.